TriviumVet is an animal therapeutics company headquartered in Waterford, Ireland. The company is focused on bridging the treatment gaps in veterinary care for companion animals. TriviumVet collaborates with human healthcare and pharmaceutical businesses to bring healthcare applications to the veterinary market, including veterinary pharmaceuticals, medical devices, and diagnostic solutions. The company's pipeline includes patented, proprietary technology and pharmaceuticals that are completing regulatory pathways with the European Medical Agency and the Food and Drug Administration. Since its establishment in 2015, TriviumVet has demonstrated a commitment to innovation through in-house research and collaboration with leading human healthcare companies. While specific details about the last investment and investors are not available, TriviumVet's approach to leveraging partnerships and advancing new healthcare solutions has positioned the company as a noteworthy player in the veterinary therapeutics industry. As TriviumVet continues to navigate regulatory pathways and expand its portfolio of veterinary care solutions, its emphasis on collaboration with human healthcare and pharmaceutical businesses sets the stage for potential growth and impact in the evolving landscape of companion animal healthcare. Followers can stay updated on the latest developments from TriviumVet by connecting with the company on Facebook, Twitter, and LinkedIn.
There is no investment information
No recent news or press coverage available for TriviumVet .